These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-000876-14 A multicentre, multinational, parallel, randomised, double blind clinical trial, to evaluate the non-inferiority of Prolonged Release Torasemide (PR) versus Immediate Release Torasemide (IR) in patien... not-yet-due
Not reported 2005-004825-25 CITICOLINE IN THE TREATMENT OF ACUTE ISCHEMIC STROKE. AN INTERNATIONAL RANDOMIZED MULTICENTER PLACEBO-CONTROLLED STUDY 2012-05-22 due-trials
Listed as ongoing, but also has a completion date 2008-007055-28 GF-001001-00 cream. A multicentre, randomised, double-blind, parallel, placebo-controlled phase II study to assess the efficacy and safety of 3 different doses of GF-001001-00 cream versus placebo cr... 2010-03-26 bad-data
Listed as ongoing, but also has a completion date 2009-016655-21 A Multi-Centre, Randomized, Placebo-controlled, Parallel-Group, double-Blinded Study to Compare the Therapeutic Efficacy, Safety and Tolerability of 3 Single Vaginal Doses of Arasertaconazole Nitrate ... 2010-11-15 bad-data
Completed, but no date 2010-019720-32 Cardiovascular Fixed Combination Pill ASR: ensayo clínico farmacodinámico de la combinación a dosis fijas de ácido acetilsalicílico, simvastatina, y ramipril (Cardiovascular Polypill); Colesterol LDL ... bad-data
Ongoing 2011-000972-32 Estudio randomizado, abierto, con endpoint enmascarado, cruzado, de dosis única para comparar la farmacodinamia de TORASEMIDA- LP 10 mg, TORASEMIDA-LI 10 mg y FUROSEMIDA-LI 40 mg en pacientes con insu... not-yet-due
Not reported 2011-003032-31 A phase III 3 arms, multicenter, randomised, investigator-blind study to assess the efficacy and safety of ozenoxacin 1% cream applied twice daily for 5 days versus placebo in the treatment of patient... 2012-12-28 due-trials
No trial status on register 2012-000746-36 A phase I open-label multiple dose study to examine the systemic bioavailability and safety of twice daily topical applications of ozenoxacin 1% cream formulation in patients with impetigo bad-data
Listed as ongoing, but also has a completion date 2014-000228-52 A phase III 2 arms, multicenter, randomised, double-blind study to assess the efficacy and safety of ozenoxacin 1% cream applied twice daily for 5 days versus placebo in the treatment of patients with... 2015-05-30 bad-data
Reported results 2014-000456-29 EFFICACY AND SAFETY OF INHALED LOXAPINE COMPARED WITH IM ANTIPSYCHOTIC IN ACUTELY AGITATED PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER 2016-10-31 due-trials
Not reported 2014-001966-87 Double-blind, randomized, placebo-controlled cross-over dose finding study of two doses of lorediplon in adult patients with insomnia disorder 2016-08-23 due-trials
Ongoing 2015-003331-36 A Phase IV, Open-label, Non-randomized, Clinical Trial to Evaluate the Safety of self-administered ADASUVE(R) (Staccato loxapine for inhalation) in Agitated Patients outside the hospital setting not-yet-due
Ongoing 2015-005717-80 Clinical trial of phase 1/2 to evaluate the feasibility, safety, tolerability and preliminary efficacy of the administration of FAB117-HC, a drug whose active ingredient is HC016, allogeneic adipose d... not-yet-due
Ongoing 2016-004015-13 A phase III, international, multicenter, randomized and openlabel study to evaluate the efficacy on LDLc and blood pressure reduction and safety of Trinomia® versus usual care in patients with high ca... not-yet-due
Ongoing 2017-002343-14 A multicentre, randomised, open-label, parallel-group trial to study the safety and non-inferiority of a new therapeutic strategy (the Fuster-CNIC-Ferrer cardiovascular polypill) versus usual care on ... not-yet-due